Almost $15 million awarded to academics in the latest National Health and Medical Research Council (NHMRC) Ideas round.
The nine research projects from School of Allied Health and Human Performance, School of Pharmacy and Biomedical Science, School of Medicine and School of Biological Sciences will share in a total of $14.5 million.
Adelaide University Deputy Vice Chancellor - Research and Innovation, Professor Anton Middelberg FTSE FNAI congratulated recipients.
“Adelaide University will build on the strong success of its foundation institutions, and the announcement of these NHMRC grants are a strong example of this,” said Professor Middelberg.
“These grants will enable continued research around health challenges faced by society, and have the potential to improve the lives of those across Australia.”
Researchers to receive grants are:
Professor Renee Turner, School of Pharmacy and Biomedical Science, who will receive $3,518,060 for a study exploring the microbiota-gut-brain axis to break the cycle of post-stroke secondary neurodegeneration.
Associate Professor Susan Woods, School of Medicine, was successful in applying for two grants totalling $2.35 million for projects to prevent and treat colorectal cancer.
Professor Christina Bursill, School of Medicine, will receive $1,236,439 for research into the novel atheroprotective properties use of Diroximel Fumarate.
Associate Professor Martin Donnelley, School of Medicine and Robinson Research Institute, will receive $1,949,781 for his work to improve paediatric respiratory outcomes using x-ray velocimetry functional imaging.
Dr Clare van Eyk, School of Medicine and Robinson Research Institute, will receive $1,496,610 to investigate patient-derived cellular models of white matter injury in cerebral palsy.
Dr Anna Sheppard, School of Biological Sciences, was granted $777,551 for her work tracking antimicrobial resistance genes.
Professor Maria Kambanaros, School of Allied Health and Human Performance, will receive $902, 037 to develop a virtual interactive platform to treat anomic language.
Dr Ashley Meakin, School of Pharmacy and Biomedical Science, will receive $2,273,632 to work on breaking the cycle of poor maternal, fetal and offspring cardiometabolic health in hyperandrogenic pregnancies.